Microba Life Sciences (ASX:MAP) Asset Turnover: 0.16 (As of Dec. 2025)


What is Microba Life Sciences Asset Turnover?

Microba Life Sciences ASX:MAP +2.56% Asset Turnover is 0.16 as of Dec. 2025. The stock has 6 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Microba Life Sciences's Revenue for the six months ended in Dec. 2025 was A$7.32 Mil. Microba Life Sciences's Total Assets for the quarter that ended in Dec. 2025 was A$45.40 Mil. Therefore, Microba Life Sciences's Asset Turnover for the quarter that ended in Dec. 2025 was 0.16.

Asset Turnover is linked to ROE % through Du Pont Formula. Microba Life Sciences's annualized ROE % for the quarter that ended in Dec. 2025 was -67.37%. It is also linked to ROA % through Du Pont Formula. Microba Life Sciences's annualized ROA % for the quarter that ended in Dec. 2025 was -46.51%.

Microba Life Sciences  (ASX:MAP) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Microba Life Sciences's annulized ROE % for the quarter that ended in Dec. 2025 is

ROE %**(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-21.112/31.3365
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-21.112 / 14.64)*(14.64 / 45.396)*(45.396/ 31.3365)
=Net Margin %*Asset Turnover*Equity Multiplier
=-144.21 %*0.3225*1.4487
=ROA %*Equity Multiplier
=-46.51 %*1.4487
=-67.37 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Microba Life Sciences's annulized ROA % for the quarter that ended in Dec. 2025 is

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=-21.112/45.396
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-21.112 / 14.64)*(14.64 / 45.396)
=Net Margin %*Asset Turnover
=-144.21 %*0.3225
=-46.51 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Microba Life Sciences Asset Turnover Related Terms

Microba Life Sciences Asset Turnover Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Asset Turnover Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Asset Turnover
0.12 0.13 0.23 0.30

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Asset Turnover Get a 7-Day Free Trial Premium Member Only 0.06 0.14 0.15 0.15 0.16

ASX:MAP vs TMO, DHR, IDXX: Asset Turnover Comparison

For the Diagnostics & Research subindustry, Microba Life Sciences's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences Asset Turnover vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Asset Turnover falls into.


Microba Life Sciences Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Microba Life Sciences's Asset Turnover for the fiscal year that ended in Jun. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2025 )/( (Total Assets (A: Jun. 2024 )+Total Assets (A: Jun. 2025 ))/ count )
=15.669/( (58.04+47.437)/ 2 )
=15.669/52.7385
=0.30

Microba Life Sciences's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=7.32/( (47.437+43.355)/ 2 )
=7.32/45.396
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.16 mean?
Microba Life Sciences (ASX:MAP) has a Asset Turnover of 0.16 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Microba Life Sciences and its competitors.
Is Microba Life Sciences' Asset Turnover too high?
Microba Life Sciences' current Asset Turnover is 0.16.
How does Microba Life Sciences' Asset Turnover compare to TMO and DHR?
Microba Life Sciences' Asset Turnover of 0.16 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Diagnostics & Research company?
A good Asset Turnover depends on the Medical Diagnostics & Research industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Microba Life Sciences and its competitors. Microba Life Sciences's current Asset Turnover is 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84% below its estimated fair value. The current Asset Turnover is 0.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Asset Turnover is 0.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.